KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Jagannath S, Lin Y, Goldschmidt H, Reece D, Nooka A, Senin A, Rodriguez-Otero P, Powles R, Matsue K, Shah N, Anderson LD, Streetly M, Wilson K, Le HV, Swern AS, Agarwal A, Siegel DS

Publication

Blood cancer journal

Publication ID (Profile URL)

https://researcherprofiles.org/profile/207295598

Publication Year

2021

PubMed ID

34145225

Publication Title

Jagannath S, Lin Y, Goldschmidt H, Reece D, Nooka A, Senin A, Rodriguez-Otero P, Powles R, Matsue K, Shah N, Anderson LD, Streetly M, Wilson K, Le HV, Swern AS, Agarwal A, Siegel DS. KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma. Blood Cancer J. 2021 06 18; 11(6):116.